Dr Boreham’s Crucible: Starpharma looks to DEP-art from the pack with a tighter focus

As with a stand-up comedian performing before an audience of accountants – or, even worse, actuaries – drug developers face a tough crowd.

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.ntnews.com.au)